
Sign up to save your podcasts
Or
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018
BMC Public Health
The CDC characterizes the opioid epidemic in three waves: first, prescription opioids (1999-2010); second, heroin (2011-2013); and third, synthetic opioids (2013-present). The authors examine the epidemic, looking at trends in multiple substances involved in overdoses and differences by race. Psychostimulant and benzodiazepine involvement were more common among White persons, while cocaine-related deaths were higher among Black persons. Overdose deaths have increased faster among Black persons since 2013. Overall, overdose deaths frequently involve multiple substances and can’t simply be attributed to opioids. The authors give three policy implications for their findings: 1) polysubstance use should be considered the norm, 2) addressing racial disparities requires interventions across primary, secondary, and tertiary prevention, and 3) the importance of measures to address fentanyl specifically.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
4.9
77 ratings
Polysubstance mortality trends in White and Black Americans during the opioid epidemic, 1999–2018
BMC Public Health
The CDC characterizes the opioid epidemic in three waves: first, prescription opioids (1999-2010); second, heroin (2011-2013); and third, synthetic opioids (2013-present). The authors examine the epidemic, looking at trends in multiple substances involved in overdoses and differences by race. Psychostimulant and benzodiazepine involvement were more common among White persons, while cocaine-related deaths were higher among Black persons. Overdose deaths have increased faster among Black persons since 2013. Overall, overdose deaths frequently involve multiple substances and can’t simply be attributed to opioids. The authors give three policy implications for their findings: 1) polysubstance use should be considered the norm, 2) addressing racial disparities requires interventions across primary, secondary, and tertiary prevention, and 3) the importance of measures to address fentanyl specifically.
Read this issue of the ASAM Weekly
Subscribe to the ASAM Weekly
Visit ASAM
129 Listeners
707 Listeners
281 Listeners
253 Listeners
3,336 Listeners
31 Listeners
1,323 Listeners
716 Listeners
290 Listeners
562 Listeners
122 Listeners
33 Listeners
175 Listeners
112 Listeners
17 Listeners